BioGlue Surgical Adhesive (BG3000 / BG3500 Series) - Surgical adhesive/sealant, animal-derived
Access comprehensive regulatory information for BioGlue Surgical Adhesive (BG3000 / BG3500 Series) - Surgical adhesive/sealant, animal-derived in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Cryolife Medical (Australia) Company Pty Ltd, manufactured by Artivion Inc in United States of America. The device registration started on April 20, 2007.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
BioGlue Surgical Adhesive is indicated for use as an adjunct to standard methods of surgical repair (such as sutures, staples, and/or patches) to adhere, seal, and/or reinforce soft tissue. Indicated soft tissues are cardiac, vascular, pulmonary, and dural.